Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Temoporfin 6mg/6ml solution for injection vials
0801050AKAAADAD
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | 1 |
|
Foscan 1mg/1ml solution for injection vials
0801050AKBBABAB
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 20mg/5ml solution for injection vials
0801050AKBBAAAA
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 3mg/3ml solution for injection vials
0801050AKBBACAC
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 6mg/6ml solution for injection vials
0801050AKBBADAD
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Temoporfin 1mg/1ml solution for injection vials
0801050AKAAABAB
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Temoporfin 20mg/5ml solution for injection vials
0801050AKAAAAAA
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Temoporfin 3mg/3ml solution for injection vials
0801050AKAAACAC
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.